Company: DARE
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001401914-25-000050
Chunk: 48

Company: Dare Bioscience, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 48
---
 operations were as follows: Three Months EndedSeptember 30,Nine Months EndedSeptember 30,2025202420252024Operating lease cost$202,000 $194,000 $626,000 $585,000 Finance lease costAmortization of finance lease449,000 — 1,047,000 — Interest on finance lease liability48,000 — 120,000 — Total lease cost$699,000 $194,000 $1,793,000 $585,000 Maturities of the Company's finance and operating lease liabilities as of September 30, 2025 were as follows:YearOperating LeasesFinance LeaseTotal2025 (remaining)$166,000 $459,000 $625,000 2026680,000 1,652,000 2,332,000 2027130,000 — 130,000 Total lease payments976,000 2,111,000 3,087,000 Less: amount representing interest(78,000)(76,000)(154,000)Present value of lease liabilities$898,000 $2,035,000 $2,933,000 

19

The weighted-average remaining lease terms and discount rates related to the Company's leases were as follows:As of September 30,20252024Weighted-average remaining lease term (in years)Operating leases1.672.67Finance lease1.25— Weighted-average discount rateOperating leases10.5 %10.5 %Finance lease9.5 %— %Supplemental cash flow information related to the Company's leases was as follows:Three Months Ended September 30,Nine Months EndedSeptember 30,2025202420252024Cash paid for amounts included in the measurement of lease liabilitiesFinancing cash flows from finance lease$— $— $917,700 $— Operating cash flows from finance lease$48,000 $— $120,000 $— Operating cash flows from operating leases$164,900 $160,200 $493,900 $478,700 

7.    ROYALTY INTEREST FINANCING

In December 2023, the Company entered into a royalty interest financing agreement, or the Royalty Interest Agreement, with United in Endeavour, LLC, or UiE, under which UiE acquired a portion of the Company